| dc.contributor |
Schweizer, Lars |
|
| dc.contributor |
Dingermann, Theodor |
|
| dc.contributor |
Russe, Otto Quintus |
|
| dc.contributor |
Jansen, Christian |
|
| dc.date |
2021-02-10T13:47:23Z |
|
| dc.date |
2021-02-10T13:47:23Z |
|
| dc.date |
2020 |
|
| dc.date.accessioned |
2023-02-17T21:17:53Z |
|
| dc.date.available |
2023-02-17T21:17:53Z |
|
| dc.identifier |
ONIX_20200615_9783030359188_52 |
|
| dc.identifier |
http://library.oapen.org/handle/20.500.12657/39579 |
|
| dc.identifier |
46218 |
|
| dc.identifier |
https://directory.doabooks.org/handle/20.500.12854/31058 |
|
| dc.identifier |
https://library.oapen.org/bitstream/20.500.12657/39579/1/2020_Book_AdvancesInPharmaBusinessManage.pdf |
|
| dc.identifier.uri |
http://localhost:8080/xmlui/handle/CUHPOERS/246027 |
|
| dc.description |
This open access book presents a unique collection of practical examples from the field of pharma business management and research. It covers a wide range of topics such as: 'Brexit and its Impact on pharmaceutical Law - Implications for Global Pharma Companies', 'Implementation of Measures and Sustainable Actions to Improve Employee's Engagement', 'Global Medical Clinical and Regulatory Affairs (GMCRA)', and 'A Quality Management System for R&D Project and Portfolio Management in a Pharmaceutical Company'. The chapters are summaries of master’s theses by "high potential" Pharma MBA students from the Goethe Business School, Frankfurt/Main, Germany, with 8-10 years of work experience and are based on scientific know-how and real-world experience. The authors applied their interdisciplinary knowledge gained in 22 months of studies in the MBA program to selected practical themes drawn from their daily business. |
|
| dc.format |
image/jpeg |
|
| dc.language |
eng |
|
| dc.publisher |
Springer Nature |
|
| dc.publisher |
Springer |
|
| dc.rights |
open access |
|
| dc.subject |
Pharmaceutical Sciences/Technology |
|
| dc.subject |
Health Care Management |
|
| dc.subject |
Medical Law |
|
| dc.subject |
Pharmacy |
|
| dc.subject |
Pharmacoeconomics and Health Outcomes |
|
| dc.subject |
Pharmaceutics |
|
| dc.subject |
Health Care |
|
| dc.subject |
Pharmacology |
|
| dc.subject |
Pharma Management |
|
| dc.subject |
Market Access |
|
| dc.subject |
Regulatory Affairs |
|
| dc.subject |
Research & Development |
|
| dc.subject |
Quality Control |
|
| dc.subject |
Open Access |
|
| dc.subject |
Industrial chemistry & chemical engineering |
|
| dc.subject |
Health economics |
|
| dc.subject |
Medical & healthcare law |
|
| dc.subject |
Pharmacy / dispensing |
|
| dc.subject |
bic Book Industry Communication::T Technology, engineering, agriculture::TD Industrial chemistry & manufacturing technologies::TDC Industrial chemistry::TDCW Pharmaceutical technology |
|
| dc.subject |
bic Book Industry Communication::K Economics, finance, business & management::KC Economics::KCQ Health economics |
|
| dc.subject |
bic Book Industry Communication::L Law::LN Laws of Specific jurisdictions::LNT Social law::LNTM Medical & healthcare law |
|
| dc.subject |
bic Book Industry Communication::M Medicine::MQ Nursing & ancillary services::MQP Pharmacy / dispensing |
|
| dc.subject |
bic Book Industry Communication::M Medicine::MM Other branches of medicine::MMG Pharmacology |
|
| dc.title |
Advances in Pharma Business Management and Research |
|
| dc.resourceType |
book |
|
| dc.alternateIdentifier |
10.1007/978-3-030-35918-8 |
|
| dc.licenseCondition |
open access |
|
| dc.licenseCondition |
n/a |
|
| dc.identifierdoi |
10.1007/978-3-030-35918-8 |
|
| dc.relationisPublishedBy |
9fa3421d-f917-4153-b9ab-fc337c396b5a |
|
| dc.pages |
85 |
|
| dc.imprint |
Springer |
|